Goldman Sachs Group Inc Organogenesis Holdings Inc. Transaction History
Goldman Sachs Group Inc
- $706 Billion
- Q2 2025
A detailed history of Goldman Sachs Group Inc transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 199,685 shares of ORGO stock, worth $904,573. This represents 0.0% of its overall portfolio holdings.
Number of Shares
199,685
Previous 422,030
52.68%
Holding current value
$904,573
Previous $1.82 Million
59.96%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding ORGO
# of Institutions
122Shares Held
69.9MCall Options Held
15.1KPut Options Held
25-
Soleus Capital Management, L.P. Greenwich, CT12.3MShares$55.9 Million3.5% of portfolio
-
Morgan Stanley New York, NY12.1MShares$54.6 Million0.0% of portfolio
-
First Light Asset Management, LLC Edina, MN6.78MShares$30.7 Million3.81% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.2MShares$23.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$23 Million0.0% of portfolio
About Organogenesis Holdings Inc.
- Ticker ORGO
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 130,888,000
- Market Cap $593M
- Description
- Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...